Assessing the 2026 Growth Potential of Beaten-Down S&P 500 Stocks

Generated by AI AgentHenry RiversReviewed byAInvest News Editorial Team
Wednesday, Dec 31, 2025 7:44 am ET6min read
Aime RobotAime Summary

- Zacks advocates buying undervalued S&P 500 stocks like

(-53%) and (-80%), citing severe pessimism already priced in.

- Both companies face short-term headwinds but maintain strong fundamentals, with Deckers trading at 15.4x forward P/E and Align investing in orthodontic R&D.

- 2026 recovery hinges on execution: Deckers' U.S. stabilization, Align's market share regain, and product launches for

.

- Risks include macroeconomic pressures, delayed product execution, and persistent North American orthodontic market weakness.

The core investment thesis from the Zacks feature is a classic contrarian play: identify strong, underperforming S&P 500 stocks trading at extreme discounts, and buy them now. The setup is clear for 2026. While artificial intelligence stocks face inevitable pullbacks, there are large-cap companies with robust fundamentals that have been crushed by a combination of their own success and macroeconomic headwinds. The argument is that their deep discounts-50% to 80% below recent highs-have already priced in severe pessimism. If their specific catalysts materialize, the path to recovery is steep.

The evidence points to two prime examples.

Brands, the parent of HOKA and UGG, is down . , the Invisalign maker, is down an even more dramatic 80% from its highs. These aren't stocks from fundamentally broken businesses. The thesis is that both companies operate strong franchises that were simply outpaced by their own explosive growth. Deckers' selloff was triggered by weaker-than-expected guidance after a period of furious expansion, compounded by tariffs, inflation, and slowing consumer spending. Technology, a "Covid superstar," saw its momentum stall post-pandemic. The core argument is one of cyclical correction, not permanent decay.

This creates a powerful valuation signal. The market's deep pessimism is already baked into the price. Deckers, for instance, is trading at a forward P/E of 15.4x, which aligns with its 20-year median. It's also trading at a discount to its industry and peers like Nike. This suggests the stock's plunge has brought it back to a historically reasonable valuation, even as its growth trajectory faces near-term pressure. The thesis is that this is the "buy the dip" moment for a durable business.

The catalyst for a rebound hinges on stabilization and execution. For Deckers, that means navigating a weak domestic consumer while its international business, particularly in China and Europe, continues to grow. For Align Technology, it's about regaining momentum in orthodontics. The Zacks analysis frames these as stocks attempting to find critical technical support and potentially breaking out in 2026. The bottom line is a bet that the market has overreacted to temporary headwinds, and the strong underlying businesses of these companies are positioned for a significant re-rating if conditions improve.

Company-Specific Catalysts and Growth Trajectories

The path to recovery for these beaten-down giants is not a single, broad-market rebound. It is a series of specific, company-driven catalysts that must play out in 2026. For each, the growth trajectory hinges on executing a distinct turnaround or expansion plan, moving beyond the sector's defensive stability to capture new market share or re-accelerate growth.

Deckers Brands faces a bifurcated challenge and opportunity. Its 2026 catalyst is about stabilizing its core U.S. market while its international engine, particularly in China, continues to roar. The company's domestic sales grew just

, a stark slowdown from its historic pace. Yet its international business, especially in China, surged 29.3%. The key for 2026 is to leverage its powerful HOKA brand to reignite U.S. demand without sacrificing the premium margins it has built. The company's strong balance sheet, with $1.4 billion in cash and equivalents, provides the dry powder to weather any U.S. softness and fund marketing or innovation to win back cost-conscious consumers. The growth trajectory depends on this stabilization, turning a lagging domestic market into a contributor rather than a drag.

Nike's 2026 catalyst is the full execution of its "Win Now" turnaround strategy. After a

, the company is in full turnaround mode, shifting focus from overexpansion to core sports like running and football. The plan involves refreshing wholesale relationships, boosting product innovation, and improving its supply chain. The critical test is whether this strategic pivot can reverse the margin compression and struggling China sales that have plagued the stock. The growth trajectory is contingent on Nike successfully reconnecting with consumers, particularly in its key North American market, and demonstrating that its product portfolio now resonates with a cost-sensitive audience.

On Holdings' 2026 catalyst is a relentless product innovation cycle. The company has set a clear goal to

, and its 2025 guidance raises have laid the groundwork. The immediate catalysts are the launches of new models: the Cloudrunner 3 and Cloudmonster 3 in the first quarter and the Cloudrunner Max in the second half. These launches, supported by a strong order book, are designed to drive the constant-currency growth needed to hit its ambitious target. The growth trajectory is directly tied to the commercial success of these new products, which must continue to outpace the market's shift toward premium running footwear.

Align Technology's 2026 catalyst is the continuation of its deep research and development program. While its stock has been crushed, the company's long-term growth is fueled by advancing its orthodontic technology. The opening of its

, with up to $300,000 in funding, is a key part of this strategy. This program supports clinical and scientific research at universities, aiming to uncover insights that directly improve treatment outcomes and elevate the standard of care. The growth trajectory depends on this R&D pipeline translating into new product advancements and clinical validation, which in turn expands the addressable market for its Invisalign system and digital platform.

Financial Health and Scalability of the Growth Model

The ability to fund growth and navigate headwinds is a critical determinant of a company's long-term trajectory. For the growth investor, the financial health of these companies reveals starkly different models of scalability and resilience.

Deckers Brands exemplifies a fortress balance sheet that provides unparalleled strategic flexibility. The company enters 2026 with a robust

. This financial strength, built on a foundation of consistent earnings and a diversified portfolio of brands like HOKA, is a direct result of disciplined capital management. It allows Deckers to weather economic uncertainty, pursue opportunistic acquisitions, and invest in its premium running shoe business without financial strain. This balance sheet is the bedrock of its growth model, enabling it to capitalize on market share gains from competitors while maintaining a low-cost path to expansion.

On Holdings, by contrast, demonstrates a scalable, high-margin business model built on direct-to-consumer dominance and premium pricing. Its financials show a powerful engine: in Q3, apparel sales surged

year-over-year, and its DTC sales mix reached a new high of . This shift is the core of its scalability, as direct sales command higher margins and build stronger customer relationships. The company's gross profit margin hit a record 65.7%, driven by this premium positioning and operational efficiencies. While it faces foreign exchange headwinds and new tariff burdens, its strong cash position and pricing power provide a buffer, allowing it to fund its global expansion and technology investments without sacrificing profitability.

Nike's financial health, however, is under significant pressure as it executes a turnaround. The company's Q4 FY25 gross margin compressed sharply to

, a 440-basis-point decline. This compression was driven by higher discounts and a less favorable channel mix, directly pressuring the profitability that funds its "Win Now" actions. The resulting 86% drop in quarterly earnings per share signals a business in transition, where aggressive marketing and restructuring costs are temporarily outweighing revenue. Its financial model is being tested, and the scalability of its growth plan hinges on successfully navigating this profitability squeeze.

Align Technology presents a different financial profile, one where a strong cash position supports a high-investment growth strategy. Despite a Q3 revenue growth of 1.8% year-over-year and a sequential decline, the company's balance sheet provides a crucial runway. Its $1.0 billion in cash is a strategic asset that funds its significant research and development investments in orthodontic technology. This financial flexibility allows Align to maintain its innovation edge and defend its market position, even during periods of slower top-line growth, ensuring its long-term scalability is not compromised by short-term revenue fluctuations.

The bottom line is that financial health is not a one-size-fits-all metric. Deckers' fortress balance sheet offers passive resilience, On's premium DTC model drives active margin expansion, Nike's model is currently under stress from its own turnaround, and Align's cash hoard funds future innovation. For the growth investor, the scalability of each model is directly tied to its financial foundation.

Catalysts, Risks, and Forward Scenarios

The path to a rebound for these beaten-down consumer discretionary stocks hinges on a few clear catalysts and a shared vulnerability to the macroeconomic climate. For each company, the near-term events and structural risks form a distinct checklist for monitoring.

For Deckers Brands, the critical catalyst is a stabilization of its domestic U.S. sales. The company's recent financials show a stark divergence: while

, domestic revenue actually decreased 1.7% in the second quarter. This weakness in its core market is the primary headwind. The company's full-year outlook assumes only low-to-mid-single-digit growth for its UGG brand, signaling a lack of confidence in a quick domestic recovery. The key near-term test is whether the momentum from strong international markets, particularly in China and Europe, can offset U.S. softness. Investors should watch for sequential improvements in U.S. DTC sales and wholesale orders, as well as any updates on tariff impacts and consumer sentiment. The overarching risk is that a persistent slowdown in U.S. discretionary spending, which has affected peers like Nike and Target, continues to pressure Deckers' core business.

On Holdings' growth trajectory depends entirely on the successful execution of its product pipeline. The company has raised its full-year 2025 sales growth forecast to

, but this momentum requires new models to sustain it. The commercial success of the Cloudrunner 3 and Cloudmonster 3 in the first quarter of 2026 is a critical near-term catalyst. More importantly, the launch of the new Cloudrunner Max in the second half of 2026 will showcase its engineering advancements and drive future growth. The risk here is execution: any delay or underwhelming market reception of these new models could break the current acceleration. The company's premium valuation, trading at a forward P/E of 28.85, leaves little room for error.

Align Technology faces a more specific and persistent headwind: softness in the North American orthodontic market. Management has explicitly cited this region as a key challenge, with Q3 revenue growth of just

and sequential declines in its core Clear Aligner volume. The catalyst is a recovery in this critical market, which is the company's largest. This will depend on the effectiveness of its go-to-market initiatives with dental service organizations and its ability to drive patient conversion. The risk is that the slowdown in North America persists, forcing the company to rely even more heavily on international growth, which is subject to its own economic and competitive pressures.

The overarching risk for all three is the macroeconomic environment. Consumer spending, particularly on discretionary items like premium footwear and orthodontic care, is sensitive to inflation and economic uncertainty. The demand from China, a key growth market for Deckers and a contributor to Align's international sales, is also cyclical. If the consumer spending environment does not improve as expected, it could undermine the growth catalysts for each company, prolonging their periods of underperformance.

author avatar
Henry Rivers

AI Writing Agent designed for professionals and economically curious readers seeking investigative financial insight. Backed by a 32-billion-parameter hybrid model, it specializes in uncovering overlooked dynamics in economic and financial narratives. Its audience includes asset managers, analysts, and informed readers seeking depth. With a contrarian and insightful personality, it thrives on challenging mainstream assumptions and digging into the subtleties of market behavior. Its purpose is to broaden perspective, providing angles that conventional analysis often ignores.

Comments



Add a public comment...
No comments

No comments yet